FRANK KARBE
CIK 1276700 · Chief Financial Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.23M
Companies
7
Total Filings
66
Lifetime Open-Market Net
-$911.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Director | 91,622 | $10.37 | $950.1K | $99.1K | 8 | 2026-05-21 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Financial Officer | 43,125 | $221.38 | $9.55M | $0 | 3 | 2026-01-07 |
| Better Therapeutics, Inc. (BTTX) Delisted | Chief Executive Officer | 526,516 | $0.04 | $23.5K | $404.7K | 5 | 2023-12-20 |
| Myovant Sciences Ltd. (MYOV) Delisted | Principal Fin'l & Accounting | 212,296 | $26.98 | $5.73M | -$1.52M | 21 | 2021-07-09 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | — | — | — | $0 | 3 | 2020-05-28 |
| ABUS | Director | — | $4.26 | — | $0 | 3 | 2017-06-23 |
| EXEL | EVP and CFO | 99,430 | $53.13 | $5.28M | $106.5K | 23 | 2014-02-18 |
Recent Filings · Page 5 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-17 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-07 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2015-08-14 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2014-02-18 | EXEL | Mixed | +1,097 | $0 | EDGAR |
| 2013-11-15 | EXEL | Mixed | +1,220 | $0 | EDGAR |
| 2013-09-19 | EXEL | Grant (A) | — | $0 | EDGAR |
| 2013-08-16 | EXEL | Mixed | +1,220 | $0 | EDGAR |
| 2013-05-17 | EXEL | Mixed | +1,218 | $0 | EDGAR |
| 2013-02-15 | EXEL | Mixed | +1,038 | $0 | EDGAR |
| 2012-11-16 | EXEL | Mixed | +1,237 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.